Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.
BACKGROUND: The correlation between xeroderma pigmentosum group D (XPD) polymorphisms (Lys751Gln and Asp312Asn) and clinical outcomes of non-small cell lung cancer (NSCLC) patients, who received platinum-based chemotherapy (Pt-chemotherapy), is still inconclusive. This meta-analysis was aimed to sys...
Main Authors: | Mantang Qiu, Xin Yang, Jingwen Hu, Xiangxiang Ding, Feng Jiang, Rong Yin, Lin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3747109?pdf=render |
Similar Items
-
XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
by: Mantang Qiu, et al.
Published: (2013-01-01) -
Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
by: Wenting Wu, et al.
Published: (2012-01-01) -
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
by: Qin Qin, et al.
Published: (2013-01-01) -
The Association between Polymorphisms of XPD and Susceptibility of Lung Cancer: A meta Analysis
by: Zhifang JIA, et al.
Published: (2009-10-01) -
The Association of XPD G312A Polymorphism with Lung Cancer Risk: a meta-analysis
by: Qinghua ZHOU, et al.
Published: (2010-05-01)